Clinical Trials · NCT04921124
Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- Enrollment
- 30
- Start date
- May 2021
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Concentration over time assessed by the area under the curve (AUC) of teriparatide (PTH (1-34)).